Home › Markets › Health Care › EMBC

Embecta Corp. (EMBC)

EMBC trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$6.20
+3.51% on the day
Market cap
$351.3M
Small cap
Revenue · 2025
$1.1B
-3.8% on 2024
Net income · 2025
$95.4M
8.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerEMBC on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001872789
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$1.1B
Net income$95.4M
Operating income$242.1M
Net margin8.8%
Operating margin22.4%
Revenue growth-3.8%
Cash$201.3M
Total assets$1.1B
P/E (computed)3.7×
P/S (computed)0.3×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentDRS2021-07-15
Latest annual report10-K2025-11-25
Latest quarterly / interim10-Q2026-08-07
Latest current report8-K2026-08-07
Latest proxy
SCHEDULE 14A
DEFA14A2026-01-23

Source: SEC EDGAR submissions feed, 262 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+3.6%
1 month+20.3%
3 months+82.8%
Year to date-48.4%
1 year-54.1%
From 52-week high-58.2%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
SIShoulder Innovations Inc.$18.07-0.88%$376.2M
OFIXOrthofix Medical Inc. Common Stock (DE)$9.26-0.22%$377.2M
CARLCarlsmed Inc.$14.47-2.10%$395.1M
CLPTClearPoint Neuro Inc.$9.81-3.82%$299.2M
RCELAvita Medical Inc.$13.36-0.07%$413.2M
NPCENeuropace Inc.$12.68-2.46%$435.2M
MOBIMobia Medical Inc.$8.50-1.16%$283.0M
ANIKAnika Therapeutics Inc.$20.53+0.29%$274.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier